daewoong pharma csp uk

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

South Korean SK Biopharmaceuticals Co. launched its epilepsy treatment Cenobamate in the UK, rapidly expanding the company’s presence in Europ...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

SeAH Steel Holdings Corp. ’s UK subsidiary is set to supply monopiles, steel tubes that serve as a fixed foundation for offshore wind turbines...

London-based M&G Investments expects the logistics and residential real estate markets in most parts of Europe to continue to offer attractive r...

Hanwha Systems Co., the defense and air mobility unit of Hanwha Group, is investing $300 million in UK’s satellite communications firm OneWeb ...

As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...

South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

The recent decision by Barbour, the British lifestyle brand under J. Barbour & Sons Ltd., to transfer the rights to sell its products in South K...

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...

A UK-focused real estate debt fund, managed by New York-based BentallGreenOak, has received a combined £170 million ($241 million) in commitme...

Samsung Electronics Co. and Germany’s pharmaceutical giant Bayer AG have made a joint investment in the Berlin-based artificial intelligence (...

Samsung Life Insurance Co. has agreed to buy a 25% stake in Savills Investment Management (Savills IM) for £63.75 million ($90 million) from U...

South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...

For Dongkuk Steel Mill Co., South Korea’s third-largest steelmaker, Companhia Siderurgica do Pecem steel mill in Brazil, commonly known as CSP...

The National Pension Service has committed $150 million to London-based Stafford Capital Partners in its first investment in timberland, land availa...

A British urban air mobility project, in which South Korea’s Hyundai Motor Co. is a technology partner, has been chosen as the winner of the U...

Two leading South Korean banks – Shinhan and Hana – have provided a combined 47 million pounds ($63 million) in senior loans to finance ...

Nuveen, the investment management arm of TIAA, is one of the world’s largest investment managers with over US$1 trillion in AUM as of 30 J...

Hyundai Mobis Co., South Korea’s largest auto parts maker, said on Oct. 7 it will invest $25 million in a UK automotive smart display company in...

South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...

The National Pension Service (NPS) has committed between $100 million and $200 million to an energy and infrastructure fund set up by UK-based private...

SeAH Steel Holdings Corporation is gearing up to construct the world's biggest monopile facility for offshore wind turbines following a memorandum of ...

Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...

South Korean institutional investors are on track to pour nearly $1 billion into US and UK airports in 2019, including the planned $51 million co-inve...

The Military Mutual Aid Association (MMAA) has invested 40 billion won ($34 million) to buy a minority stake in Welcome Break, the UK’s second biggest...

A consortium of Dalmore Capital and Equitix Investment Management will sell down a stake in Cross London Trains (XLT) to three South Korean brokerage ...